The Procter & Gamble Company (NYSE:PG – Free Report) – Equities researchers at William Blair decreased their Q2 2025 EPS estimates for Procter & Gamble in a research report issued to clients and investors on Monday, November 25th. William Blair analyst J. Andersen now expects that the company will earn $1.90 per share for the quarter, down from their previous estimate of $1.92. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.96 per share. William Blair also issued estimates for Procter & Gamble’s Q4 2025 earnings at $1.54 EPS.
Several other analysts also recently weighed in on PG. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. DA Davidson upgraded shares of Procter & Gamble from a “neutral” rating to a “buy” rating and raised their price target for the stock from $160.00 to $209.00 in a report on Monday. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a research note on Monday, September 30th. Wells Fargo & Company lifted their price target on shares of Procter & Gamble from $188.00 to $190.00 and gave the company an “overweight” rating in a research note on Friday, November 22nd. Finally, Evercore ISI increased their target price on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Eight research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $180.45.
Procter & Gamble Stock Up 0.0 %
Shares of PG opened at $179.36 on Wednesday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The firm’s 50-day simple moving average is $170.37 and its 200 day simple moving average is $168.98. Procter & Gamble has a 52 week low of $142.50 and a 52 week high of $180.43. The firm has a market cap of $422.40 billion, a P/E ratio of 30.92, a price-to-earnings-growth ratio of 3.82 and a beta of 0.42.
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the prior year, the company posted $1.83 earnings per share. Procter & Gamble’s revenue was down .6% on a year-over-year basis.
Institutional Trading of Procter & Gamble
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Acorn Creek Capital LLC boosted its stake in shares of Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after purchasing an additional 59 shares in the last quarter. Patrick M Sweeney & Associates Inc. boosted its position in Procter & Gamble by 1.1% during the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after acquiring an additional 59 shares in the last quarter. Hudson Value Partners LLC grew its holdings in shares of Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock worth $250,000 after acquiring an additional 60 shares during the period. Traveka Wealth LLC lifted its stake in shares of Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after purchasing an additional 60 shares during the period. Finally, Fiduciary Alliance LLC boosted its position in shares of Procter & Gamble by 2.8% during the second quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after purchasing an additional 61 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Insider Buying and Selling
In related news, CEO Jon R. Moeller sold 7,007 shares of the business’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the transaction, the chief executive officer now owns 269,172 shares in the company, valued at $46,203,373.80. The trade was a 2.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the sale, the insider now owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. This trade represents a 52.47 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 35,233 shares of company stock worth $6,024,234 in the last ninety days. 0.18% of the stock is owned by insiders.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.24%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 69.48%.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- ESG Stocks, What Investors Should Know
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.